Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5306/wjco.v12.i2.54 http://scihub22266oqcxt.onion/10.5306/wjco.v12.i2.54 33680873!7918523!33680873     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33680873&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       World+J+Clin+Oncol 2021 ; 12 (2): 54-60 Nephropedia Template TP {{tp|p=33680873|t=2021. Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?|pdf=|usr=}}{{33680873}} gab.com Text Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils JO: World J Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33680873 #FOAvip Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population. We are experiencing a paradigm shift in the treatment of pancreatic cancer in the era of coronavirus disease 2019 (COVID-19) pandemic. Utilizing neoadjuvant treatment and further conducting a safe surgery while protecting patients in a controlled environment can improve oncological outcomes. On the other hand, an optimal oncologic procedure performed in a hazardous setting could shorten patient survival if recovery is complicated by COVID-19 infection. We believe that oncological treatment protocols must adapt to this new health threat, and pancreatic cancer is not unique in this regard. Although survival may not be as optimistic as most other malignancies, as caregivers and researchers, we are committed to innovating and reshaping the treatment algorithms to minimize morbidity and maximize survival as caregivers and researchers. Twit Text FOAVip Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils ????World J Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33680873 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33680873 #FOAvip English Wikipedia <ref>{{Cite pmid|33680873}}</ref> Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils? #MMPMID33680873 Moslim MA; Hall MJ; Meyer JE; Reddy SS World J Clin Oncol 2021[Feb]; 12 (2): 54-60 PMID33680873show ga Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population. We are experiencing a paradigm shift in the treatment of pancreatic cancer in the era of coronavirus disease 2019 (COVID-19) pandemic. Utilizing neoadjuvant treatment and further conducting a safe surgery while protecting patients in a controlled environment can improve oncological outcomes. On the other hand, an optimal oncologic procedure performed in a hazardous setting could shorten patient survival if recovery is complicated by COVID-19 infection. We believe that oncological treatment protocols must adapt to this new health threat, and pancreatic cancer is not unique in this regard. Although survival may not be as optimistic as most other malignancies, as caregivers and researchers, we are committed to innovating and reshaping the treatment algorithms to minimize morbidity and maximize survival as caregivers and researchers. ?Pancreatic cancer in the era of COVID-19 pandemic: Which one is the le(epmc).pdf DeepDyve Pubget Overpricing